Mutant prevention concentrations of colistin for Acinetobacter baumannii, pseudomonas aeruginosa and Klebsiella pneumoniae clinical isolates

Journal of Antimicrobial Chemotherapy

Volumn 69, Issue 1, 2014, Pages 275-277

  Choi, Myung Jin ^a   Ko, Kwan Soo ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

MSW; Mutant selection window; Polymyxins; Two component systems

Indexed keywords

COLISTIN; IMIPENEM;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIUM ISOLATE; KLEBSIELLA PNEUMONIAE; LETTER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PSEUDOMONAS AERUGINOSA;

MSW; MUTANT SELECTION WINDOW; POLYMYXINS; TWO-COMPONENT SYSTEMS;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; AMINO ACID SUBSTITUTION; ANTI-BACTERIAL AGENTS; COLISTIN; GENES, BACTERIAL; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; MUTATION, MISSENSE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SELECTION, GENETIC;

EID: 84890349383     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkt315     Document Type: Letter

References (10)

1. Livermore DM. Current epidemiology and growing resistance of Gram-negative pathogens. Korean J Intern Med 2012; 27: 128-42.
2. Blondeau JM. New concepts in antimicrobial susceptibility testing: the mutant prevention concentration and mutant selection window approach. Vet Dermatol 2009; 20: 383-96.
3. Peck KR, Kim MJ, Cho JY et al. In vitro time-kill studies of antimicrobial agents against blood isolates of imipenem-resistant Acinetobacter baumannii, including colistin- or tigecycline-resistant isolates. J Med Microbiol 2012; 61: 353-60.
4. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-first Informational Supplement M100-S21. CLSI, Wayne, PA, USA, 2011.
5. Credito K, Kosowska-Shick K, Appelbaum PC. Mutant prevention concentrations of four carbapenems against gram-negative rods. Antimicrob Agents Chemother 2010; 54: 2692-5.
6. Cai Y, Li R, Liang B et al. In vitro antimicrobial activity and mutant prevention concentration of colistin against Acinetobacter baumannii. Antimicrob Agents Chemother 2010; 54: 3998-9.
7. Hawley JS, Murray CK, Jorgensen JH. Colistin heteroresistance in Acinetobacter and its association with previous colistin therapy. Antimicrob Agents Chemother 2008; 52: 351-2.
8. Park YK, Choi JY, Shin D et al. Correlation between overexpression and amino acid substitution of the PmrAB locus and colistin resistance in Acinetobacter baumannii. Int J Antimicrob Agents 2011; 37: 525-30.
9. Moffatt JH, Harper M, Harrison P et al. Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production. Antimicrob Agents Chemother 2010; 54: 4971-7.
10. Adams MD, Nickel GC, Bajaksouzian S et al. Resistance to colistin in Acinetobacter baumannii associated with mutations in the PmrAB two-component system. Antimicrob Agents Chemother 2009; 53: 3628-34.